These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16498394)

  • 1. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.
    Della Porta MG; Malcovati L; Invernizzi R; Travaglino E; Pascutto C; Maffioli M; Gallì A; Boggi S; Pietra D; Vanelli L; Marseglia C; Levi S; Arosio P; Lazzarino M; Cazzola M
    Leukemia; 2006 Apr; 20(4):549-55. PubMed ID: 16498394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
    Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
    Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.
    Malcovati L; Della Porta MG; Lunghi M; Pascutto C; Vanelli L; Travaglino E; Maffioli M; Bernasconi P; Lazzarino M; Invernizzi R; Cazzola M
    Leukemia; 2005 May; 19(5):776-83. PubMed ID: 15789068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
    Tehranchi R; Invernizzi R; Grandien A; Zhivotovsky B; Fadeel B; Forsblom AM; Travaglino E; Samuelsson J; Hast R; Nilsson L; Cazzola M; Wibom R; Hellström-Lindberg E
    Blood; 2005 Jul; 106(1):247-53. PubMed ID: 15755901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
    Violidaki D; Axler O; Jafari K; Bild F; Nilsson L; Mazur J; Ehinger M; Porwit A
    Cytometry B Clin Cytom; 2020 Sep; 98(5):399-411. PubMed ID: 32543774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
    Kárai B; Bedekovics J; Miltényi Z; Gergely L; Szerafin L; Ujfalusi A; Kappelmayer J; Hevessy Z
    Int J Lab Hematol; 2017 Dec; 39(6):577-584. PubMed ID: 28625017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of flow cytometry in detecting dysplasia of myelodysplastic syndromes].
    Li J; He GS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1069-72. PubMed ID: 23998614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.
    Eidenschink Brodersen L; Menssen AJ; Wangen JR; Stephenson CF; de Baca ME; Zehentner BK; Wells DA; Loken MR
    Cytometry B Clin Cytom; 2015 Mar; 88(2):125-35. PubMed ID: 25490867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.
    Westers TM; Cremers EM; Oelschlaegel U; Johansson U; Bettelheim P; Matarraz S; Orfao A; Moshaver B; Brodersen LE; Loken MR; Wells DA; Subirá D; Cullen M; Te Marvelde JG; van der Velden VH; Preijers FW; Chu SC; Feuillard J; Guérin E; Psarra K; Porwit A; Saft L; Ireland R; Milne T; Béné MC; Witte BI; Della Porta MG; Kern W; van de Loosdrecht AA;
    Haematologica; 2017 Feb; 102(2):308-319. PubMed ID: 27758818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
    Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
    Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors.
    Invernizzi R; Travaglino E; Della Porta MG; Gallì A; Malcovati L; Rosti V; Bergamaschi G; Erba BG; Bellistri F; Bastia R; Santambrogio P; Levi S; Cazzola M
    Br J Haematol; 2013 Jun; 161(5):726-737. PubMed ID: 23573868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
    Della Porta MG; Lanza F; Del Vecchio L;
    Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
    Laranjeira P; Rodrigues R; Carvalheiro T; Constanço C; Vitória H; Matarraz S; Trindade H; Órfão A; Paiva A
    Leuk Res; 2015 Mar; 39(3):361-70. PubMed ID: 25582385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDS.
    Kornblau SM; Cohen AC; Soper D; Huang YW; Cesano A
    Cytometry B Clin Cytom; 2014 Nov; 86(6):383-96. PubMed ID: 24106013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.
    Stetler-Stevenson M; Arthur DC; Jabbour N; Xie XY; Molldrem J; Barrett AJ; Venzon D; Rick ME
    Blood; 2001 Aug; 98(4):979-87. PubMed ID: 11493442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
    Cazzola M; Invernizzi R; Bergamaschi G; Levi S; Corsi B; Travaglino E; Rolandi V; Biasiotto G; Drysdale J; Arosio P
    Blood; 2003 Mar; 101(5):1996-2000. PubMed ID: 12406866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High erythroferrone expression in CD71
    Riabov V; Mossner M; Stöhr A; Jann JC; Streuer A; Schmitt N; Knaflic A; Nowak V; Weimer N; Obländer J; Palme I; Schumann C; Baldus CD; Schulze TJ; Wuchter P; Röhl H; Jawhar A; Weiss C; Boch T; Metzgeroth G; Neumann M; Hofmann WK; Nolte F; Nowak D
    Br J Haematol; 2021 Mar; 192(5):879-891. PubMed ID: 33486765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms.
    Kern W; Bacher U; Schnittger S; Alpermann T; Haferlach C; Haferlach T
    Cytometry B Clin Cytom; 2013 May; 84(3):194-7. PubMed ID: 23283847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.